Big Issues Changemakers in health and disability are working to improve the lives of those marginalised by society.
It was an everyday situation that became a nightmare no parent should have to face. Two-year-old Ava Hodgkinson was under the ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Vertex could be close to a price deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...
There are already cystic fibrosis drugs on the market ... where NICE rejected regular NHS funding for its Orkambi combination therapy. Vertex is trying to negotiate a price covering Orkambi ...
A BBC Morning Live regular, Dr Oscar Duke, is warning that although rare, it is possible to get an infection due ot your home ...
A BBC Morning Live doctor has said that whilst mould may look unsightly, it could be causing more issues than just making ...
The major work programmes mapped out in this Plan are underpinned by an agreed, costed and phased NHS technology plan, ...
Core20PLUS5 is a national NHS England approach to inform action to reduce healthcare inequalities at both national and system level. The approach defines a target population – the ‘Core20PLUS’ – and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback